Identification and Validation of BATF3 as a Promising BiomarkerGene for Peripheral T-cell Lymphoma
By combining machine learning, MR, and experimental validation, we identified and validated BATF3 as a promising biomarker of PTCL. These findings provide insights into the molecular mechanisms underlying PTCL and may inform the development of effective treatment strategies for this disease.
Authors
- Yidong Zhu (ORCID: https://orcid.org/0000-0002-8505-8257)
- Jun Liu (ORCID: https://orcid.org/0000-0001-5072-3205)
- Ting Zhang (ORCID: https://orcid.org/0000-0002-6100-8327)
Institutions
- Tongji University (CN)
- Shanghai Tenth People's Hospital (CN)
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2025-05-02
- DOI
- https://doi.org/10.2174/0109298673367678250414061434
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00